Changeflow GovPing Healthcare & Life Sciences Gamma-GT Reagent Safety Notice, VitalScientific
Priority review Notice Added Final

Gamma-GT Reagent Safety Notice, VitalScientific

Favicon for ansm.sante.fr ANSM Drug & Device Safety Alerts
Detected
Email

Summary

ANSM registered safety action R2610705 initiated by VitalScientific concerning Gamma-GT and Gamma-GT Plus SL biochemical reagents. Affected laboratory users received a direct communication from VitalScientific outlining the safety action. ANSM directs further enquiries to the manufacturer.

“L'ANSM a été informée de la mise en œuvre d'une action de sécurité effectuée par la société Vital Scientific.”

ANSM , verbatim from source
Published by ANSM on ansm.sante.fr . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

ANSM has formally recorded a safety action by VitalScientific covering its Gamma-GT and Gamma-GT Plus SL biochemical reagents, assigned reference number R2610705. The safety communication from VitalScientific to affected users is attached to the ANSM notice and dated 21 April 2026.

Medical laboratories using VitalScientific Gamma-GT or Gamma-GT Plus SL reagents should review the manufacturer's correspondence for any required follow-up actions. Questions about the scope or substance of the safety action should be directed to VitalScientific directly.

Archived snapshot

Apr 21, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Information n° R2610705 destinée aux laboratoires d'analyses de biologie médicale L'ANSM a été informée de la mise en œuvre d’une action de sécurité effectuée par la société Vital Scientific.
Les utilisateurs concernés ont reçu le courrier ci-joint.

Cette action de sécurité est enregistrée à l’ANSM sous le n° R2610705.
Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Consultez le courrier de la société Vital Scientific (21/04/2026)

Get daily alerts for ANSM Drug & Device Safety Alerts

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from ANSM.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
ANSM
Instrument
Notice
Branch
Executive
Source language
fr
Legal weight
Non-binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Medical device makers Healthcare providers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Diagnostic reagent distribution Laboratory safety notification
Geographic scope
France FR

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Product Safety Healthcare

Get alerts for this source

We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!